After Fresenius deal collapse, Akorn inks $74M settlement with investors over data integrity woes

After Fresenius deal collapse, Akorn inks $74M settlement with investors over data integrity woes

Source: 
Fierce Pharma
News Tags: 
snippet: 

Akorn has had a busy two years in court following a flurry of data integrity woes that led former merger partner Fresenius to walk away from their deal. Now, it’s putting one issue to rest by settling with investors who lost money during the tumultuous stretch.